Skip to main navigation Skip to search Skip to main content

Prostanoid receptors in GtoPdb v.2021.2

Lucie Clapp, Mark Giembycz, Akos Heinemann, Robert L. Jones, Shuh Narumiya, Xavier Norel, Yukihiko Sugimoto, David F. Woodward, Chengcan Yao

Research output: Contribution to journalArticle

Abstract

Prostanoid receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Prostanoid Receptors [694]) are activated by the endogenous ligands prostaglandins PGD2, PGE1, PGE2 , PGF2α, PGH2, prostacyclin [PGI2] and thromboxane A2. Differences and similarities between human and rodent prostanoid receptor orthologues, and their specific roles in pathophysiologic conditions are reviewed in [448]. Measurement of the potency of PGI2 and thromboxane A2 is hampered by their instability in physiological salt solution; they are often replaced by cicaprost and U46619, respectively, in receptor characterization studies.
Original languageEnglish
JournalIUPHAR/BPS Guide to Pharmacology CITE
Volume2021
Issue number2
DOIs
Publication statusPublished - 25 Jun 2021

Fingerprint

Dive into the research topics of 'Prostanoid receptors in GtoPdb v.2021.2'. Together they form a unique fingerprint.

Cite this